- Record: found
- Abstract: found
- Article: not found
Risk factors for renal impairment in patients with solid tumors or multiple myeloma treated with zoledronic acid.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Using retrospective prescription analysis, this study aimed to investigate the risk factors for renal impairment among adult solid tumor and multiple myeloma patients who have received zoledronic acid injections in a teaching hospital over the last 4 years.